O6-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions
- 1 June 2005
- Vol. 54 (6), 797-802
- https://doi.org/10.1136/gut.2004.059535
Abstract
Background and aims: O6-methylguanine methyltransferase (MGMT) repairs inappropriately methylated guanine in DNA. MGMT mutations have not previously been reported in cancers, but in colorectal tumours MGMT promoter methylation is common and has been associated with increased G:C>A:T transitions, a high frequency of K-ras mutations, and low level microsatellite instability (MSI low). However, some have suggested that MGMT changes are background or secondary events, with little importance for tumorigenesis. Methods: We have analysed fresh frozen colorectal cancers and colorectal cancer cell lines for MGMT changes: mutations, allelic loss, and protein expression. Results: Six of 113 cancers harboured somatic missense MGMT mutations, at least three of which probably caused reduced MGMT function and were accompanied by silencing or loss of the wild-type allele. Cancers with pathogenic MGMT mutations tended to harbour G:C>A:T somatic mutations at other loci. Overall, MGMT expression was reduced or lost in more than half of the cancers. We found no association between MGMT expression and the somatic mutation spectrum at APC, beta-catenin, K-ras, or p53, but decreased MGMT expression was weakly associated with the presence of a G:C>A:T change at any one of these loci. Reduced MGMT expression was not however associated with an increased frequency of K-ras mutations or with MSI low. Conclusion: In summary, we found that mutation of MGMT contributes to decreased protein function. Our findings provide good evidence to show that MGMT changes, including methylation, are selected rather than background events, at least in some cases. Decreased MGMT expression or function probably has a weak or moderate effect on the mutation spectrum in colorectal cancers.Keywords
This publication has 30 references indexed in Scilit:
- Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrumOncogene, 2004
- MSI‐low, a real phenomenon which varies in frequency among cancer typesThe Journal of Pathology, 2003
- Conserved residue lysine165 is essential for the ability of O6-alkylguanine‒DNA alkyltransferase to react with O6-benzylguanineBiochemical Journal, 2000
- Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O6-alkylguanine‒DNA alkyltransferase insensitive to O6-benzylguanineBiochemical Journal, 2000
- Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-->AT transition in the K-ras oncogeneCarcinogenesis: Integrative Cancer Research, 1997
- The methylation status of the gene for O6-methylguanine-DNA methyltransferase in human Mer+ and Mer− cellsCarcinogenesis: Integrative Cancer Research, 1995
- Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colonCarcinogenesis: Integrative Cancer Research, 1995
- Structure, Function, and Inhibition of O6-Alkylguanine-DNA AlkyltransferaseProgress in Nucleic Acid Research and Molecular Biology, 1995
- In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcriptionBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Specific amino acid sequences required for O6-methylguanine-DNA methyltransferase activity: analyses of three residues at or near the methyl acceptor siteCarcinogenesis: Integrative Cancer Research, 1992